Scott OI Borgetti

Dr. Scott OI Borgetti

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
ALAlfredo J. Mena Lora
Alfredo J. Mena Lora
RBRodrigo Burgos
Rodrigo Burgos
SBScott OI Borgetti
Scott OI Borgetti
LCLelia H. Chaisson
Lelia H. Chaisson
SBSusan C. Bleasdale
Susan C. Bleasdale
Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with remdesivir restrictions were more guideline concordant. Formulary restrictions can be important for pandemic response.

6 October 2025 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
LCLior Cohen-Yatziv
Lior Cohen-Yatziv
ALAlfredo Mena Lora
Alfredo Mena Lora
AGAlan E. Gross
Alan E. Gross
JAJenna Adams
Jenna Adams
NINahed Ismail
Nahed Ismail
SBScott OI Borgetti
Scott OI Borgetti
Faced with a national blood culture bottle shortage, our institution formed a multidisciplinary stewardship team and implemented policy changes. This reduced orders by 60%, potentially saving $145,000 monthly, while maintaining stable in-hospital sepsis mortality rates.

30 June 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
ALAlfredo J. Mena Lora
Alfredo J. Mena Lora
RBRodrigo Burgos
Rodrigo Burgos
SBScott OI Borgetti
Scott OI Borgetti
LCLelia H. Chaisson
Lelia H. Chaisson
SBSusan C. Bleasdale
Susan C. Bleasdale
COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies were common and approval by infectious disease physicians often required.

1 April 2024 in Journal of Correctional Health Care
Verified
Journal Article
Closed access
NPNivedha Poondi
Nivedha Poondi
JHJysheng Hou
Jysheng Hou
SMSarah M. Michienzi
Sarah M. Michienzi
MPMahesh Patel
Mahesh Patel
SBScott OI Borgetti
Scott OI Borgetti
MBMelissa E Badowski
Melissa E Badowski
Screening upon entry into prison for hepatitis A virus (HAV) and hepatitis B virus (HBV) provides an ideal public health opportunity to offer vaccination to individuals who are nonimmune. We conducted a retrospective review of HAV and HBV immunity among adults living with HIV in the Illinois Department of Corrections between January 1, 2019, and December 31, 2019. The primary objective was to assess rates of HAV and/or HBV immunity in individuals with HIV. In total, 436 people were included in the study. Of 425 patients who had data for HAV vaccination, 335 were immune. Of 421 patients who had data for HBV vaccination, 272 were immune. Of the 149 patients who were nonimmune to HBV, 22 had active HBV and 6 had an equivocal HBV surface antibody and negative HBV surface antigen. In total, 212 (52%) were immune to both HAV and HBV, and 31 (8%) had no immunity to either HAV or HBV. These data demonstrate an important opportunity to discuss and provide vaccination while in custody.

24 June 2021 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
SBScott OI Borgetti
Scott OI Borgetti
AGAlan E. Gross
Alan E. Gross
JKJaney Kottler
Janey Kottler
KPKenil Patel
Kenil Patel
JPJamie Paek
Jamie Paek
JRJon Radosta
Jon Radosta

30 June 2024 in Transplant Infectious Disease
Verified
Journal Article
Closed access
RKRyan Knodle
Ryan Knodle
BPBen Pomerantz
Ben Pomerantz
SBScott OI Borgetti
Scott OI Borgetti